Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Gupta: Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in.... (0.13 sec) 

Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the …


AK Gupta, B Dahlof, J Dobson, PS Sever, H … - Diabetes Care, 2008 - Am Diabetes Assoc
RESULTS—NOD was significantly associated with an increase in baseline fasting
plasma glucose (FPG), BMI, serum triglycerides, and systolic blood pressure. In
contrast, amlodipine ± perindopril in comparison with atenolol ± thiazide ...
Cited by 5 - Related articles - BL Direct - All 4 versions

First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and …


W Zidek, J Schrader, S Lüders, S Matthaei, … - Cardiovascular Diabetology, 2008 - cardiab.com
The ADaPT investigation ("ACE inhibitor-based versus diuretic-based
antihypertensive primary treatment in patients with pre-diabetes") is a 4-year
open, prospective, parallel group phase IV study. It compares an ...
Cited by 5 - Related articles - Cached - All 9 versions

Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes.

- nursing2008.com
DP Macfarlane, KR Paterson, M Fisher - pt.wkhealth.com
Given the long-term health consequences and increasing incidence of type 2
diabetes, there is great interest to potentially prevent or delay its onset.
Primary prevention studies have demonstrated that intensive exercise and ...
Cited by 6 - Related articles - All 5 versions

Prevention of diabetes and cardiovascular disease in patients with impaired glucose …


RM Califf, M Boolell, SM Haffner, MA Bethel … - American Heart Journal, 2008 - pt.wkhealth.com
Cited by 8 - Related articles - All 3 versions

New-onset diabetes, antihypertensive treatment, and outcome

- ahajournals.org
P Verdecchia, F Angeli, G Reboldi - Hypertension, 2007 - Am Heart Assoc
In the analysis of the VALUE database, all-cause mortality (HR: 0.61; 95% CI:
0.48 to 0.77) and cardiac mortality (HR: 0.44; 95% CI: 0.28 to 0.70) were lower,
not higher, in the subjects with NOD than in their nondiabetic ...
Cited by 13 - Related articles - All 5 versions

Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial


TA Aksnes, SE Kjeldsen, M Rostrup, Ö Störset … - Journal of human hypertension, 2008 - nature.com
Diabetes mellitus often develops in patients with hypertension. We investigated
predictors of diabetes mellitus development in hypertensives at risk of
developing the disease in the VALUE trial population. Among the 9995 non- ...
Cited by 4 - Related articles - All 4 versions

DETERMINANTS OF NEW-ONSET DIABETES AMONG 19,257 HYPERTENSIVE PATIENTS …

- diabetesjournals.org [PDF] 
AK Gupta, B Dahlof, J Dobson, PS Sever, H … - Diabetes Care, 2008 - Am Diabetes Assoc
1. International Centre for Circulatory Health, National Heart & Lung Institute,
Imperial College London 2. Sahlgrenska University Hospital/Ostra, Goteborg,
Sweden 3. Nordic School of Public Health, Goteborg, Sweden
Cited by 4 - Related articles - All 4 versions

Thiazide-induced dysglycemia: it's time to take notice


RM Cooper-DeHoff - Expert Rev. Cardiovasc. Ther., 2008 - expert-reviews.com
Despite these insightful recommendations, benzothiadiazine derivatives (most
often hydrochlorothiazide [HCTZ]) are the first-line recommended therapy for
hypertension, regardless of glycemic status [2]. Epidemiologic data, as ...
Related articles - All 4 versions

Antihypertensive Drugs and New-Onset Diabetes: A Retrospective Longitudinal Cohort …


GP Jong, MH Chang, L Tien, SY Li, YS Liou, … - Cardiovascular Therapeutics, 2009 - interscience.wiley.com
Antihypertensive drugs have been linked to new-onset diabetes (NOD); however,
data on the effect of these drugs on the development of NOD in hypertensive
patients has not been well determined. We aimed to investigate the ...
Related articles - All 2 versions

Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic …


JH Karnes, RM Cooper-DeHoff - Expert Review of Cardiovascular Therapy, 2009 - ingentaconnect.com
For almost as long as thiazide diuretics and b-blockers have been available,
there has been concern over their metabolic effects. While in
somecasestheseconcernshaveleadtopreferential prescribing of other ...
Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google